If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksInspiration Hlt Regulatory News (IHC)

Share Price Information for Inspiration Hlt (IHC)

Share Price is delayed by 15 minutes
Get Live Data
19.50    0.00 (0.00%)
Bid:
19.00
Ask:
20.00
Spread: 1.00 (5.263%)
Market Cap: £17.48m
IHC Live PriceLast checked at - London Stock Exchange

Intraday Inspiration Hlt Share Chart

Agreements with Atom Medical and EPMC Pharma

9 Jun 2016 07:00

RNS Number : 6473A
Inspiration Healthcare Group PLC
09 June 2016
 

9 June 2016

 

 

Inspiration Healthcare Group plc

("Inspiration Healthcare", the "Company" or the "Group")

 

 

Agreements signed with 

Atom Medical and EPMC Pharma

 

Inspiration Healthcare Group plc (AIM: IHC), the global medical device company, is pleased to announce that it has signed a one year rolling contract with Atom Medical, the largest manufacturer of incubators in Japan, and a five year contract with EPMC Pharma for the sale of its sucrose products in the UK and Ireland.

The agreement with Atom follows on from the acquisition of Inditherm plc last year with whom Atom had a prior agreement and means the enlarged Group will retain the exclusive rights to sell the wide range of Atom products used in Neonatal Intensive Care Units in the UK.

Atom manufactures a range of specialist incubators used in Neonatal Intensive Care, some of which can be combined with other products sold by Inspiration Healthcare. These include the Acutronic range of ventilators and other neonatal products such as the warming product CosyTherm.

At the same time the Company is pleased to report that it has signed a five year agreement with EPMC Pharma of Belgium, which produces Algopedol, (24% sucrose), an aqueous sterile oral solution used to reduce neonatal pain. Sucrose is currently predominantly used in a hospital environment and it is expected that it will progressively be adopted in the wider medical community. Since 2003, Inspiration has been the UK market leader in the distribution of single dose sucrose products in the UK.

Commenting today, Neil Campbell, Chief Executive Officer, said:

"We are delighted to continue our relationship with Atom Medical with whom the Group has worked for many years and very excited about the opportunity it gives us to combine their incubators with other medical products we sell. It cements our ability to supply a comprehensive range of capital equipment into the NICU and will help build our reputation as a one stop shop of neonatal intensive care equipment in the UK and Ireland.

"We are also pleased to announce today, the agreement with EPMC Pharma, which reinforces our leading position in this area, and look forward to being able to develop this market further."

Further information on Inspiration Healthcare can be seen at www.inspiration-healthcare.com

Enquiries:

Inspiration Healthcare Group plc

Neil Campbell, Chief Executive Officer

01709 761000

WH Ireland Limited

(Nominated Adviser and Broker)

Tim Feather

Liam Gribben

0113 394 6600

Cadogan PR

Alex Walters

07771 713608

About Inspiration Healthcare

Inspiration Healthcare (AIM: IHC) is a global supplier of medical technology for critical care, operating theatre and other medical applications. The Company provides high quality innovative products to patients and caregivers around the world that help to improve patient outcomes and efficiencies of healthcare organisations with patient focused customer service and technical support.

The Company's own brand of critical care solutions span non-invasive respiratory management, thermoregulation and diagnostics, and patient warming for newborns through to adults in intensive care and the operating theatre, whilst the distribution business supplies solutions to support specialised surgical procedures and infusion therapies.

Present in over 50 countries worldwide, Inspiration Healthcare's success has been built on continuous innovation, excellent customer service and an inherent commitment to improving the quality of life of patients, working in close collaboration with key opinion leaders and stakeholders in the clinical and medical community across the globe.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAAKFDBQBKDDAK
Date   Source Headline
26th Jun 202611:00 amRNSAnnual Report and Notice of AGM
16th Jun 20267:00 amRNSFinal Results
2nd Jun 20267:01 amRNSNotice of Results
2nd Jun 20267:00 amRNSTransfer of Non-Core Products to Focus on Neonatal
14th Apr 20267:00 amRNSChange of Adviser
16th Mar 20269:33 amRNSHolding(s) in Company
16th Mar 20269:33 amRNSHolding(s) in Company
5th Mar 20267:00 amRNSUK neonatal division wins NHS framework agreement
26th Feb 20269:23 amRNSHolding(s) in Company
12th Feb 20267:00 amRNSFull year trading update
10th Feb 20269:05 amRNSHolding(s) in Company
3rd Feb 20267:00 amRNSAppointment of Joint Broker
2nd Feb 202611:01 amRNSHolding(s) in Company
28th Jan 20261:40 pmRNSHolding(s) in Company
28th Jan 20267:00 amRNSPurchasing agreement in the US
27th Jan 20269:46 amRNSHolding(s) in Company
26th Jan 202610:02 amRNSHolding(s) in Company
22nd Jan 20261:37 pmRNSHolding(s) in Company
26th Nov 20257:00 amRNSChange of auditor
16th Oct 20251:51 pmRNSHolding(s) in Company
7th Oct 20257:00 amRNSHalf-year Report
23rd Sep 20257:00 amRNSResults presentations for analysts and investors
19th Sep 20257:00 amRNSDirectorate Change
20th Aug 20257:00 amRNSTrading update and notice of results
24th Jul 20251:37 pmRNSResult of AGM
24th Jul 20257:00 amRNSAGM Statement
13th Jun 20259:16 amRNSPublication of AR, accounts & notice of AGM
6th Jun 20257:00 amRNSBoard Change
28th May 20257:00 amRNSUnaudited Preliminary results
23rd May 20257:00 amRNSNotice of Results
15th May 20255:01 pmRNSHolding(s) in Company
15th May 202510:06 amRNSHolding(s) in Company
1st Apr 202511:36 amRNSHolding(s) in Company
21st Mar 20252:49 pmRNSGrant of Options
12th Mar 20256:01 pmRNSHolding(s) in Company
12th Mar 20256:00 pmRNSDirector/PDMR Shareholding
24th Feb 20254:16 pmRNSDirector/PDMR Shareholding
21st Feb 20252:52 pmRNSDirector/PDMR Shareholding
18th Feb 20257:00 amRNSTrading update
10th Feb 20259:54 amRNSHolding(s) in Company
28th Jan 20257:00 amRNSDirectorate Change
14th Jan 20254:08 pmRNSHolding(s) in Company
12th Dec 20247:00 amRNSAppointment of Chief Executive Officer
14th Nov 20247:00 amRNSBoard Change
4th Nov 20247:00 amRNSGrant of Covenant Waiver and Covenant Reset
2nd Oct 20247:00 amRNSHalf-year Report
17th Sep 202412:26 pmRNSResult of AGM
3rd Sep 20247:00 amRNSTrading update for the six months to 31 July 2024
5th Aug 20243:41 pmRNSHolding(s) in Company
2nd Aug 20247:00 amRNSNominated adviser and broker

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.